|Articles|March 1, 2002
- Pharmaceutical Technology-03-02-2002
- Volume 26
- Issue 3
Drug Safety Concerns Shape Manufacturing Policy
Author(s)Jill Wechsler
FDA wants manufacturers to revise product labeling and packaging and step up adverse-event monitoring to reduce risky product use.
Advertisement
Articles in this issue
over 23 years ago
Outsourcing Outlookover 23 years ago
Developing Custom Adhesive Systems for Transdermal Drug Deliveryover 23 years ago
PDA Task Force Issues Guidelines to Aid Isolator Usersover 23 years ago
Production Information Mangementover 23 years ago
Validation Changes to the USP Assay Method for Ibuprofen Tabletsover 23 years ago
Systematic Troubleshooting for LC/MS/MSNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
